Research programme: anti-inflammatory and anti-fibrotic therapeutics - GenfitAlternative Names: TGFTX4; TGFTX5
Latest Information Update: 17 Oct 2015
At a glance
- Originator Genfit
- Class Small molecules
- Mechanism of Action Receptor protein-tyrosine kinase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatic fibrosis; Inflammatory bowel diseases
Most Recent Events
- 17 Oct 2015 Early research in Inflammatory bowel disease in France (unspecified route)
- 17 Oct 2015 Early research in Hepatic fibrosis in France (unspecified route)